Elizabeth Ingram
Director Ejecutivo en Cipla Therapeutics, Inc. .
Perfil
Elizabeth G.
Ingram is currently the President & Chief Executive Officer at Cipla Therapeutics, Inc. She previously served as an Independent Director at Avenue Therapeutics, Inc. from 2019 to 2022.
Prior to that, she was the Vice President-Market Access Strategy at Bristol Myers Squibb Co. from 2012 to 2014.
Elizabeth also held the position of Chief Marketing Officer at MannKind Corp.
in 2018 and was the Senior Vice President-Managed Market at DexCom, Inc. in 2017.
She completed her undergraduate degree at East Carolina University and her graduate degree at the University of South Carolina.
Cargos activos de Elizabeth Ingram
Empresas | Cargo | Inicio |
---|---|---|
Cipla Therapeutics, Inc. | Director Ejecutivo | - |
Antiguos cargos conocidos de Elizabeth Ingram.
Empresas | Cargo | Fin |
---|---|---|
AVENUE THERAPEUTICS, INC. | Director/Miembro de la Junta | 31/10/2022 |
MANNKIND CORPORATION | Ventas & Marketing | 01/06/2019 |
DEXCOM, INC. | Corporate Officer/Principal | 01/12/2017 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2014 |
Formación de Elizabeth Ingram.
East Carolina University | Undergraduate Degree |
University of South Carolina | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
MANNKIND CORPORATION | Health Technology |
DEXCOM, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
AVENUE THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Cipla Therapeutics, Inc. |
- Bolsa de valores
- Insiders
- Elizabeth Ingram